Patient Resources

Brostallicin Clinical Trial for Myxoid Liposarcoma

Pharmatech, Inc. is managing a clinical trial sponsored by Systems Medicine, LLC.  The trial is a Phase 2 open-label clinical study of an experimental drug called Brostallicin, for the treatment of patients with myxoid liposarcoma with a (12;16) translocation. The cancer must be metastatic or unresectable and standard curative or palliative measures do not exist or are not effective. Patients with myxoid liposarcoma may wish to discuss the Brostallicin trial with their doctors to see if it may be right for them.  For more information about the trial and to find a participating trial site, please visit http://www.pharmatech.com/clinicaltrials.html or call 1-866-383-6610 x160 or email .(JavaScript must be enabled to view this email address).

Programs & Resources

Patient Resources

Information on sarcoma subtypes, treatments, clinical trials, and other important resources for sarcoma patients and families.

Sarcoma Patient Registry

Information on the Sarcoma Patient Registry. If you are diagnosed with sarcoma, please consider joining the Registry.

Research Grants

Information on applying for a sarcoma research grant, current research funded by the SFA, and past research grants.